| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $842.4M | -0.7% |
| R&D Expense | $237.2M | +77.1% |
| SG&A Expense | $185.3M | +51.0% |
| Operating Income | -$113.9M | -180.8% |
| Interest Expense | $10.8M | +231.2% |
| Income Tax | -$409K | +76.1% |
| Net Income | -$108.7M | -180.2% |
| EPS (Basic) | -$1.31 | -175.7% |
| EPS (Diluted) | -$1.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Total Assets | $1.94B | +6.4% |
| Total Liabilities | $1.26B | +24.7% |
| Stockholders' Equity | $672.4M | -16.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$674.7M | -500.8% |
| Capital Expenditures | $8.8M | +4.7% |
| Investing Cash Flow | -$114.1M | +20.7% |
| Financing Cash Flow | $130.0M | -84.8% |
| Free Cash Flow | -$683.5M | -527.4% |
| -191.6% |